<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2&amp;ff=20240516040944&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2&amp;ff=20240516040944&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Thu, 16 May 2024 08:09:45 +0000</lastbuilddate>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Reply: Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749628/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):e195-e196. doi: 10.1016/j.jacc.2024.03.393.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749628/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749628</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.393>10.1016/j.jacc.2024.03.393</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749628</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Aish Sinha</dc:creator>
<dc:creator>Haseeb Rahman</dc:creator>
<dc:creator>Divaka Perera</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function</dc:title>
<dc:identifier>pmid:38749628</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.393</dc:identifier>
</item>
<item>
<title>The Complex and Incomplete Relationship Between Exercise Stress Testing and Coronary Microvascular Dysfunction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749627/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):e193-e194. doi: 10.1016/j.jacc.2024.02.047.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749627/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749627</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.047>10.1016/j.jacc.2024.02.047</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749627</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Steven E S Miner</dc:creator>
<dc:creator>John A Blair</dc:creator>
<dc:creator>Mary C McCarthy</dc:creator>
<dc:creator>Lynne E Nield</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Complex and Incomplete Relationship Between Exercise Stress Testing and Coronary Microvascular Dysfunction</dc:title>
<dc:identifier>pmid:38749627</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.047</dc:identifier>
</item>
<item>
<title>False Reassurance: Limitations of Relying on Stress Testing for Diagnosis of CMD</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749626/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):e191. doi: 10.1016/j.jacc.2024.02.046.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749626/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749626</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.046>10.1016/j.jacc.2024.02.046</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749626</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Ori Waksman</dc:creator>
<dc:creator>Kalyan R Chitturi</dc:creator>
<dc:creator>Brian C Case</dc:creator>
<dc:creator>Hayder D Hashim</dc:creator>
<dc:creator>Ron Waksman</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>False Reassurance: Limitations of Relying on Stress Testing for Diagnosis of CMD</dc:title>
<dc:identifier>pmid:38749626</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.046</dc:identifier>
</item>
<item>
<title>Exercise Electrocardiographic Stress Test for Diagnosing Coronary Microvascular Dysfunction: Tale as Old as Time?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749625/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):e189. doi: 10.1016/j.jacc.2024.02.048.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749625/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749625</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.048>10.1016/j.jacc.2024.02.048</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749625</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Kyriakos Dimitriadis</dc:creator>
<dc:creator>Nikolaos Pyrpyris</dc:creator>
<dc:creator>Konstantinos Tsioufis</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Exercise Electrocardiographic Stress Test for Diagnosing Coronary Microvascular Dysfunction: Tale as Old as Time?</dc:title>
<dc:identifier>pmid:38749625</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.048</dc:identifier>
</item>
<item>
<title>Exercise Stress Testing Specificity in Patients With ANOCA: Beware When Applying to a General Population</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749624/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):e187-e188. doi: 10.1016/j.jacc.2024.02.049.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749624/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749624</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.049>10.1016/j.jacc.2024.02.049</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749624</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Ricardo O Escárcega</dc:creator>
<dc:creator>Kamaldeep Singh</dc:creator>
<dc:creator>Richard A Chazal</dc:creator>
<dc:creator>Malissa J Wood</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Exercise Stress Testing Specificity in Patients With ANOCA: Beware When Applying to a General Population</dc:title>
<dc:identifier>pmid:38749624</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.049</dc:identifier>
</item>
<item>
<title>Correction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749623/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):2035. doi: 10.1016/j.jacc.2024.04.005.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749623/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749623</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.04.005>10.1016/j.jacc.2024.04.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749623</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Correction</dc:title>
<dc:identifier>pmid:38749623</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.04.005</dc:identifier>
</item>
<item>
<title>RESPONSE: Meeting the Need for Nutrition Education in Cardiology: Are We Wise Enough to Follow Trainees?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749622/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):2030-2031. doi: 10.1016/j.jacc.2024.03.391.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749622/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749622</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.391>10.1016/j.jacc.2024.03.391</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749622</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Andrew M Freeman</dc:creator>
<dc:creator>Stephen Devries</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>RESPONSE: Meeting the Need for Nutrition Education in Cardiology: Are We Wise Enough to Follow Trainees?</dc:title>
<dc:identifier>pmid:38749622</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.391</dc:identifier>
</item>
<item>
<title>Improving Diet Interventions by Health Systems: Calling on All FITs</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749621/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):2028-2031. doi: 10.1016/j.jacc.2024.03.379.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749621/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749621</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.379>10.1016/j.jacc.2024.03.379</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749621</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Sana Ahmad</dc:creator>
<dc:creator>Emilie Rembert</dc:creator>
<dc:creator>Chloe Duvall</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Improving Diet Interventions by Health Systems: Calling on All FITs</dc:title>
<dc:identifier>pmid:38749621</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.379</dc:identifier>
</item>
<item>
<title>Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749620/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>The identification of the pulmonary veins as a trigger source for atrial fibrillation (AF) has established pulmonary vein isolation (PVI) as a key target for AF ablation. However, PVI alone does not prevent recurrent AF in many patients, and numerous additional ablation strategies have failed to improve on PVI outcomes. This therapeutic limitation may be due, in part, to a failure to identify and intervene specifically on the pro-fibrillatory substrate within the atria and pulmonary veins. In...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):2015-2027. doi: 10.1016/j.jacc.2024.02.050.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The identification of the pulmonary veins as a trigger source for atrial fibrillation (AF) has established pulmonary vein isolation (PVI) as a key target for AF ablation. However, PVI alone does not prevent recurrent AF in many patients, and numerous additional ablation strategies have failed to improve on PVI outcomes. This therapeutic limitation may be due, in part, to a failure to identify and intervene specifically on the pro-fibrillatory substrate within the atria and pulmonary veins. In this review paper, we highlight several emerging approaches with clinical potential that target atrial cardiomyopathy-the underlying anatomic, electrical, and/or autonomic disease affecting the atrium-in various stages of practice and investigation. In particular, we consider the evolving roles of risk factor modification, targeting of epicardial adipose tissue, tissue fibrosis, oxidative stress, and the inflammasome, along with aggressive early anti-AF therapy in AF management. Attention to combatting substrate development promises to improve outcomes in AF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749620/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749620</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.050>10.1016/j.jacc.2024.02.050</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749620</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Mark D McCauley</dc:creator>
<dc:creator>Gianluca Iacobellis</dc:creator>
<dc:creator>Na Li</dc:creator>
<dc:creator>Stanley Nattel</dc:creator>
<dc:creator>Jeffrey J Goldberger</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week</dc:title>
<dc:identifier>pmid:38749620</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.050</dc:identifier>
</item>
<item>
<title>Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749619/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>Orthotopic transcatheter tricuspid valve replacement (TTVR) devices have been shown to be highly effective in reducing tricuspid regurgitation (TR), and interest in this therapy is growing with the recent commercial approval of the first orthotopic TTVR. Recent TTVR studies report preexisting cardiac implantable electronic device (CIED) transvalvular leads in ∼35% of patients, with entrapment during valve implantation. Concerns have been raised regarding the safety of entrapping leads and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):2002-2014. doi: 10.1016/j.jacc.2024.02.045.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Orthotopic transcatheter tricuspid valve replacement (TTVR) devices have been shown to be highly effective in reducing tricuspid regurgitation (TR), and interest in this therapy is growing with the recent commercial approval of the first orthotopic TTVR. Recent TTVR studies report preexisting cardiac implantable electronic device (CIED) transvalvular leads in ∼35% of patients, with entrapment during valve implantation. Concerns have been raised regarding the safety of entrapping leads and counterbalanced against the risks of transvenous lead extraction (TLE) when indicated. This Heart Valve Collaboratory consensus document attempts to define the patient population with CIED lead-associated or lead-induced TR, describe the risks of lead entrapment during TTVR, delineate the risks and benefits of TLE in this setting, and develop a management algorithm for patients considered for TTVR. An electrophysiologist experienced in CIED management should be part of the multidisciplinary heart team and involved in shared decision making.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749619/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749619</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.045>10.1016/j.jacc.2024.02.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749619</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Rebecca T Hahn</dc:creator>
<dc:creator>Bruce Larry Wilkoff</dc:creator>
<dc:creator>Susheel Kodali</dc:creator>
<dc:creator>Ulrika Maria Birgersdotter-Green</dc:creator>
<dc:creator>Gorav Ailawadi</dc:creator>
<dc:creator>Karima Addetia</dc:creator>
<dc:creator>Martin Andreas</dc:creator>
<dc:creator>Angelo Auricchio</dc:creator>
<dc:creator>Frederick Ehlert</dc:creator>
<dc:creator>Isaac George</dc:creator>
<dc:creator>Aakriti Gupta</dc:creator>
<dc:creator>Rachel Harrison</dc:creator>
<dc:creator>Edwin C Ho</dc:creator>
<dc:creator>Fred Kusumoto</dc:creator>
<dc:creator>Azeem Latib</dc:creator>
<dc:creator>Patrick O'Gara</dc:creator>
<dc:creator>Kristen K Patton</dc:creator>
<dc:creator>Sean Pinney</dc:creator>
<dc:creator>Emily P Zeitler</dc:creator>
<dc:creator>Michael J Mack</dc:creator>
<dc:creator>Martin B Leon</dc:creator>
<dc:creator>Laurence M Epstein</dc:creator>
<dc:creator>Heart Valve Collaboratory and Heart Rhythm Society</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review</dc:title>
<dc:identifier>pmid:38749619</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.045</dc:identifier>
</item>
<item>
<title>Is There an Experience/Exposure Paradox in Interventional Cardiology?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749618/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):1999-2001. doi: 10.1016/j.jacc.2024.03.411.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749618/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749618</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.411>10.1016/j.jacc.2024.03.411</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749618</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Pinak B Shah</dc:creator>
<dc:creator>David A Gross</dc:creator>
<dc:creator>Ajar Kochar</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Is There an Experience/Exposure Paradox in Interventional Cardiology?</dc:title>
<dc:identifier>pmid:38749618</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.411</dc:identifier>
</item>
<item>
<title>Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749617/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Early-career operators are caring for patients with more acute presentations and higher predicted risk of mortality and bleeding compared with more experienced colleagues, with modestly worse outcomes. These data should inform institutional practices to support the development of early-career proceduralists.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):1990-1998. doi: 10.1016/j.jacc.2024.03.395.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Little is known about the procedural characteristics, case volumes, and mortality rates for early- vs non-early-career interventional cardiologists in the United States.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study examined operator-level data for patients who underwent percutaneous coronary intervention (PCI) between April 2018 and June 2022.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Data were collected from the National Cardiovascular Data Registry CathPCI Registry, American Board of Internal Medicine certification database, and National Plan and Provider Enumeration System database. Early-career operators were within 5 years of the end of training. Annual case volume, expected mortality and bleeding risk, and observed/predicted mortality and bleeding outcomes were evaluated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 1,451 operators were early career; 1,011 changed their career status during the study; and 6,251 were non-early career. Overall, 514,540 patients were treated by early-career and 2,296,576 patients by non-early-career operators. The median annual case volume per operator was 59 (Q1-Q3: 31-97) for early-career and 57 (Q1-Q3: 28-100) for non-early-career operators. Early-career operators were more likely to treat patients presenting with ST-segment elevation myocardial infarction and urgent indications for PCI (both P &lt; 0.001). The median predicted mortality risk was 2.0% (Q1-Q3: 1.5%-2.7%) for early-career and 1.8% (Q1-Q3: 1.2%-2.4%) for non-early-career operators. The median predicted bleeding risk was 4.9% (Q1-Q3: 4.2%-5.7%) for early-career and 4.4% (Q1-Q3: 3.7%-5.3%) for non-early-career operators. After adjustment, an increased risk of mortality (OR: 1.08; 95% CI: 1.05-1.17; P &lt; 0.0001) and bleeding (OR: 1.08; 95% CI: 1.05-1.12; P &lt; 0.0001) were associated with early-career status.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Early-career operators are caring for patients with more acute presentations and higher predicted risk of mortality and bleeding compared with more experienced colleagues, with modestly worse outcomes. These data should inform institutional practices to support the development of early-career proceduralists.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749617/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749617</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.395>10.1016/j.jacc.2024.03.395</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749617</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Jennifer A Rymer</dc:creator>
<dc:creator>Dennis I Narcisse</dc:creator>
<dc:creator>Angel Chen</dc:creator>
<dc:creator>Daniel Wojdyla</dc:creator>
<dc:creator>Sarah Ashley</dc:creator>
<dc:creator>Abdulla A Damluji</dc:creator>
<dc:creator>Binita Shah</dc:creator>
<dc:creator>Michael G Nanna</dc:creator>
<dc:creator>Rajesh Swaminathan</dc:creator>
<dc:creator>J Antonio Gutierrez</dc:creator>
<dc:creator>Anezi Uzendu</dc:creator>
<dc:creator>Adam J Nelson</dc:creator>
<dc:creator>Garrett Bethel</dc:creator>
<dc:creator>Katherine Kearney</dc:creator>
<dc:creator>W Schuyler Jones</dc:creator>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Jacob A Doll</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States</dc:title>
<dc:identifier>pmid:38749617</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.395</dc:identifier>
</item>
<item>
<title>Winning or Losing Trials: Making Better Days Matter</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749616/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):1987-1989. doi: 10.1016/j.jacc.2024.03.410.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749616/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749616</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.410>10.1016/j.jacc.2024.03.410</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749616</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Adrian F Hernandez</dc:creator>
<dc:creator>Adam D DeVore</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Winning or Losing Trials: Making Better Days Matter</dc:title>
<dc:identifier>pmid:38749616</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.410</dc:identifier>
</item>
<item>
<title>Cardiovascular Risk Stratification by LV Size Among AF Population: Smaller Is Not Always Better</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749615/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):1970-1972. doi: 10.1016/j.jacc.2024.04.004.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749615/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749615</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.04.004>10.1016/j.jacc.2024.04.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749615</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Chung-Lieh Hung</dc:creator>
<dc:creator>Ning-I Yang</dc:creator>
<dc:creator>Chern-En Chiang</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Cardiovascular Risk Stratification by LV Size Among AF Population: Smaller Is Not Always Better</dc:title>
<dc:identifier>pmid:38749615</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.04.004</dc:identifier>
</item>
<item>
<title>Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749614/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In a prospective AF cohort, small LV was independently associated with an increased risk of cardiovascular events, which needed consideration in risk stratification and management for patients with AF. (ChiCTR-OCH-13003729).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):1957-1969. doi: 10.1016/j.jacc.2024.03.394.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: It is still unclear whether small left ventricle (LV) is an adverse structural prognostic feature in patients with atrial fibrillation (AF).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this study was to evaluate the association between small LV and risk of cardiovascular events in AF population.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: From the China-AF registry, 7,764 patients with AF were enrolled and divided into groups with normal, small, and large LV size based on left ventricular end-diastolic dimension (LVEDD) measurement per the American Society of Echocardiography references. Cox models were used to assess the association between LV size or LVEDD with composite cardiovascular events (cardiovascular death, ischemic stroke or systemic embolism, or major bleeding).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: There were 308 (4.0%) participants assessed with small LV who were older, with lower body mass and blood pressure, and fewer comorbidities, and 429 (5.5%) were identified with large LV. Compared with the normal LV group, small LV and large LV were significantly associated with higher incidence of composite cardiovascular events (adjusted HR [aHR]: 1.54 [95% CI: 1.07-2.20] for small LV; aHR: 1.36 [95% CI: 1.02-1.81] for large LV) and cardiovascular death (aHR: 1.94 [95% CI: 1.14-3.28] for small LV; aHR: 1.83 [95% CI: 1.24-2.69] for large LV). Small LV was also associated with increased risk of major bleeding [aHR: 2.21 [95% CI: 1.01-4.86]). A U-shaped relationship between LVEDD and composite cardiovascular events was identified (P<sub>nonlinear</sub> &lt; 0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In a prospective AF cohort, small LV was independently associated with an increased risk of cardiovascular events, which needed consideration in risk stratification and management for patients with AF. (ChiCTR-OCH-13003729).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749614/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749614</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.394>10.1016/j.jacc.2024.03.394</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749614</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Mingxiao Li</dc:creator>
<dc:creator>Lan Ren</dc:creator>
<dc:creator>Liu He</dc:creator>
<dc:creator>Yiwei Lai</dc:creator>
<dc:creator>Jue Wang</dc:creator>
<dc:creator>Sitong Li</dc:creator>
<dc:creator>Xiaodong Peng</dc:creator>
<dc:creator>Manlin Zhao</dc:creator>
<dc:creator>Qifan Li</dc:creator>
<dc:creator>Zixu Zhao</dc:creator>
<dc:creator>Le Zhou</dc:creator>
<dc:creator>Chao Jiang</dc:creator>
<dc:creator>Song Zuo</dc:creator>
<dc:creator>Xueyuan Guo</dc:creator>
<dc:creator>Songnan Li</dc:creator>
<dc:creator>Nian Liu</dc:creator>
<dc:creator>Chenxi Jiang</dc:creator>
<dc:creator>Ribo Tang</dc:creator>
<dc:creator>Deyong Long</dc:creator>
<dc:creator>Xin Du</dc:creator>
<dc:creator>Caihua Sang</dc:creator>
<dc:creator>Jianzeng Dong</dc:creator>
<dc:creator>Changsheng Ma</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk</dc:title>
<dc:identifier>pmid:38749614</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.394</dc:identifier>
</item>
<item>
<title>Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749613/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 May 21;83(20):1953-1956. doi: 10.1016/j.jacc.2024.03.402.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749613/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749613</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.402>10.1016/j.jacc.2024.03.402</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749613</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Michael D Shapiro</dc:creator>
<dc:creator>Charles A German</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia</dc:title>
<dc:identifier>pmid:38749613</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.402</dc:identifier>
</item>
<item>
<title>An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38749423/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>Platelet dysregulation is drastically increased with advanced age and contributes to making cardiovascular disorders the leading cause of death of elderly humans. Here, we reveal a direct differentiation pathway from hematopoietic stem cells into platelets that is progressively propagated upon aging. Remarkably, the aging-enriched platelet path is decoupled from all other hematopoietic lineages, including erythropoiesis, and operates as an additional layer in parallel with canonical platelet...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 8:S0092-8674(24)00413-6. doi: 10.1016/j.cell.2024.04.018. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Platelet dysregulation is drastically increased with advanced age and contributes to making cardiovascular disorders the leading cause of death of elderly humans. Here, we reveal a direct differentiation pathway from hematopoietic stem cells into platelets that is progressively propagated upon aging. Remarkably, the aging-enriched platelet path is decoupled from all other hematopoietic lineages, including erythropoiesis, and operates as an additional layer in parallel with canonical platelet production. This results in two molecularly and functionally distinct populations of megakaryocyte progenitors. The age-induced megakaryocyte progenitors have a profoundly enhanced capacity to engraft, expand, restore, and reconstitute platelets in situ and upon transplantation and produce an additional platelet population in old mice. The two pools of co-existing platelets cause age-related thrombocytosis and dramatically increased thrombosis in vivo. Strikingly, aging-enriched platelets are functionally hyper-reactive compared with the canonical platelet populations. These findings reveal stem cell-based aging as a mechanism for platelet dysregulation and age-induced thrombosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38749423/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38749423</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.018>10.1016/j.cell.2024.04.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38749423</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Donna M Poscablo</dc:creator>
<dc:creator>Atesh K Worthington</dc:creator>
<dc:creator>Stephanie Smith-Berdan</dc:creator>
<dc:creator>Marcel G E Rommel</dc:creator>
<dc:creator>Bryce A Manso</dc:creator>
<dc:creator>Reheman Adili</dc:creator>
<dc:creator>Lydia Mok</dc:creator>
<dc:creator>Roman E Reggiardo</dc:creator>
<dc:creator>Taylor Cool</dc:creator>
<dc:creator>Raana Mogharrab</dc:creator>
<dc:creator>Jenna Myers</dc:creator>
<dc:creator>Steven Dahmen</dc:creator>
<dc:creator>Paloma Medina</dc:creator>
<dc:creator>Anna E Beaudin</dc:creator>
<dc:creator>Scott W Boyer</dc:creator>
<dc:creator>Michael Holinstat</dc:creator>
<dc:creator>Vanessa D Jonsson</dc:creator>
<dc:creator>E Camilla Forsberg</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis</dc:title>
<dc:identifier>pmid:38749423</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.018</dc:identifier>
</item>
<item>
<title>Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38750627/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In ACS patients undergoing DES implantation, ticagrelor monotherapy after short-term DAPT was associated with less major bleeding without a concomitant increase in ischaemic events compared with ticagrelor-based 12-month DAPT.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 16:ehae249. doi: 10.1093/eurheartj/ehae249. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: In patients with acute coronary syndrome (ACS), dual antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor is recommended for 12 months after drug-eluting stent (DES) implantation. Monotherapy with a potent P2Y12 inhibitor after short-term DAPT is an attractive option to better balance the risks of ischaemia and bleeding. Therefore, this study evaluated the efficacy and safety of ticagrelor monotherapy after short-term DAPT, especially in patients with ACS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Electronic databases were searched from inception to 11 November 2023, and for the primary analysis, individual patient data were pooled from the relevant randomized clinical trials comparing ticagrelor monotherapy after short-term (≤3 months) DAPT with ticagrelor-based 12-month DAPT, exclusively in ACS patients undergoing DES implantation. The co-primary endpoints were ischaemic endpoint (composite of all-cause death, myocardial infarction, or stroke) and bleeding endpoint [Bleeding Academic Research Consortium (BARC) type 3 or 5 bleeding] at 1 year.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Individual patient data from two randomized clinical trials including 5906 ACS patients were analysed. At 1 year, the primary ischaemic endpoint did not differ between the ticagrelor monotherapy and ticagrelor-based DAPT groups [1.9% vs. 2.5%; adjusted hazard ratio (HR) 0.79; 95% confidence interval (CI) 0.56-1.13; P = .194]. The incidence of the primary bleeding endpoint was lower in the ticagrelor monotherapy group (2.4% vs. 4.5%; adjusted HR 0.54; 95% CI 0.40-0.72; P &lt; .001). The results were consistent in a secondary aggregate data meta-analysis including the ACS subgroup of additional randomized clinical trials which enrolled patients with ACS as well as chronic coronary syndrome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In ACS patients undergoing DES implantation, ticagrelor monotherapy after short-term DAPT was associated with less major bleeding without a concomitant increase in ischaemic events compared with ticagrelor-based 12-month DAPT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY REGISTRATION: PROSPERO (ID: CRD42023476470).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38750627/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38750627</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae249>10.1093/eurheartj/ehae249</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38750627</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Yong-Joon Lee</dc:creator>
<dc:creator>Sanghoon Shin</dc:creator>
<dc:creator>Sung Woo Kwon</dc:creator>
<dc:creator>Yongsung Suh</dc:creator>
<dc:creator>Kyeong Ho Yun</dc:creator>
<dc:creator>Tae Soo Kang</dc:creator>
<dc:creator>Jun-Won Lee</dc:creator>
<dc:creator>Deok-Kyu Cho</dc:creator>
<dc:creator>Jong-Kwan Park</dc:creator>
<dc:creator>Jang-Whan Bae</dc:creator>
<dc:creator>Woong Cheol Kang</dc:creator>
<dc:creator>Seunghwan Kim</dc:creator>
<dc:creator>Seung-Jun Lee</dc:creator>
<dc:creator>Sung-Jin Hong</dc:creator>
<dc:creator>Chul-Min Ahn</dc:creator>
<dc:creator>Jung-Sun Kim</dc:creator>
<dc:creator>Byeong-Keuk Kim</dc:creator>
<dc:creator>Young-Guk Ko</dc:creator>
<dc:creator>Donghoon Choi</dc:creator>
<dc:creator>Yangsoo Jang</dc:creator>
<dc:creator>Myeong-Ki Hong</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials</dc:title>
<dc:identifier>pmid:38750627</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae249</dc:identifier>
</item>
<item>
<title>Efferocytosis in atherosclerosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38750215/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>Cardiovascular disease is the leading cause of death worldwide, and it commonly results from atherosclerotic plaque progression. One of the increasingly recognized drivers of atherosclerosis is dysfunctional efferocytosis, a homeostatic mechanism responsible for the clearance of dead cells and the resolution of inflammation. In atherosclerosis, the capacity of phagocytes to participate in efferocytosis is hampered, leading to the accumulation of apoptotic and necrotic tissue within the plaque,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 May 15. doi: 10.1038/s41569-024-01037-7. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular disease is the leading cause of death worldwide, and it commonly results from atherosclerotic plaque progression. One of the increasingly recognized drivers of atherosclerosis is dysfunctional efferocytosis, a homeostatic mechanism responsible for the clearance of dead cells and the resolution of inflammation. In atherosclerosis, the capacity of phagocytes to participate in efferocytosis is hampered, leading to the accumulation of apoptotic and necrotic tissue within the plaque, which results in enlargement of the necrotic core, increased luminal stenosis and plaque inflammation, and predisposition to plaque rupture or erosion. In this Review, we describe the different forms of programmed cell death that can occur in the atherosclerotic plaque and highlight the efferocytic machinery that is normally implicated in cardiovascular physiology. We then discuss the mechanisms by which efferocytosis fails in atherosclerosis and other cardiovascular and cardiometabolic diseases, including myocardial infarction and diabetes mellitus, and discuss therapeutic approaches that might reverse this pathological process.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38750215/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38750215</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01037-7>10.1038/s41569-024-01037-7</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38750215</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Shaunak S Adkar</dc:creator>
<dc:creator>Nicholas J Leeper</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Efferocytosis in atherosclerosis</dc:title>
<dc:identifier>pmid:38750215</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01037-7</dc:identifier>
</item>
<item>
<title>Correction to: Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38748452/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 15:ehae318. doi: 10.1093/eurheartj/ehae318. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38748452/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38748452</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae318>10.1093/eurheartj/ehae318</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38748452</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography</dc:title>
<dc:identifier>pmid:38748452</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae318</dc:identifier>
</item>
<item>
<title>Physical Activity and Progression of Coronary Artery Calcification in Men and Women</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38748444/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240516040944&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: This study found that PA volume was not associated with progression of CAC in a large cohort of healthy men and women who were initially free of overt cardiovascular disease.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 15. doi: 10.1001/jamacardio.2024.0759. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Prior cross-sectional studies have suggested that very high levels of physical activity (PA) are associated with a higher prevalence of coronary artery calcium (CAC). However, less is known regarding the association between high-volume PA and progression of CAC over time.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To explore the association between PA (measured at baseline and during follow-up) and the progression of CAC over time.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This cohort study included data from 8771 apparently healthy men and women 40 years and older who had multiple preventive medicine visits at the Cooper Clinic (Dallas, Texas), with a mean (SD) follow-up time of 7.8 (4.7) years between the first and last clinic visit. Participants with reported PA and CAC measurements at each visit during 1998 to 2019 were included in the study. Data were analyzed from March 2023 to February 2024.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: PA reported at baseline and follow-up, examined continuously per 500 metabolic equivalent of task minutes per week (MET-min/wk) and categorically: less than 1500, 1500 to 2999, 3000 or more MET-min/wk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Negative binomial regression was used to estimate the rate of mean CAC progression between visits, with potential modification by PA volume, calculated as the mean of PA at baseline and follow-up. In addition, proportional hazards regression was used to estimate hazard ratios for baseline PA as a predictor of CAC progression to 100 or more Agatston units (AU).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 8771 participants, the mean (SD) age at baseline was 50.2 (7.3) years for men and 51.1 (7.3) years for women. The rate of mean CAC progression per year from baseline was 28.5% in men and 32.1% in women, independent of mean PA during the same time period. That is, the difference in the rate of CAC progression per year was 0.0% per 500 MET-min/wk for men and women (men: 95% CI, -0.1% to 0.1%; women: 95% CI, -0.4% to 0.5%). Moreover, baseline PA was not associated with CAC progression to a clinically meaningful threshold of 100 AU or more over the follow-up period. The hazard ratio for a baseline PA value of 3000 or more MET-min/wk vs less than 1500 MET-min/wk to cross this threshold was 0.84 (95% CI, 0.66 to 1.08) in men and 1.16 (95% CI, 0.57 to 2.35) in women.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: This study found that PA volume was not associated with progression of CAC in a large cohort of healthy men and women who were initially free of overt cardiovascular disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38748444/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240516040944&v=2.18.0.post9+e462414">38748444</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0759>10.1001/jamacardio.2024.0759</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38748444</guid>
<pubDate>Wed, 15 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Kerem Shuval</dc:creator>
<dc:creator>David Leonard</dc:creator>
<dc:creator>Laura F DeFina</dc:creator>
<dc:creator>Carolyn E Barlow</dc:creator>
<dc:creator>Jarett D Berry</dc:creator>
<dc:creator>William M Turlington</dc:creator>
<dc:creator>Andjelka Pavlovic</dc:creator>
<dc:creator>Nina B Radford</dc:creator>
<dc:creator>Kelley Pettee Gabriel</dc:creator>
<dc:creator>Amit Khera</dc:creator>
<dc:creator>Benjamin D Levine</dc:creator>
<dc:date>2024-05-15</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Physical Activity and Progression of Coronary Artery Calcification in Men and Women</dc:title>
<dc:identifier>pmid:38748444</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0759</dc:identifier>
</item>





























</channel>
</rss>